Aster Capital Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$391K Buy
+4,991
New +$340K 0.08% 304
2026
Q1
Sell
-2,566
Closed -$173K 1052
2025
Q4
$173K Buy
2,566
+742
+41% +$49.9K 0.08% 249
2025
Q3
$134K Sell
1,824
-7,030
-79% -$467K 0.07% 328
2025
Q2
$461K Buy
+8,854
New +$504K 0.1% 230

Other funds holding HALO

Aster Capital Management's HALO Position: Q2 2026 in Review

Aster Capital Management opened a new position in Halozyme (HALO) in Q2 2026: 4,991 shares worth $391K. The stake represents 0.08% of the portfolio and ranks #304 among its holdings. This is a return to the name: Aster Capital Management previously reported a position in HALO as recently as Q4 2025.

Aster Capital Management first reported a position in HALO in Q2 2025 and has held it in 4 quarters since. The position peaked at $461K in Q2 2025. 673 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Aster Capital Management held 4,991 shares of Halozyme worth $391K as of Q2 2026.
  • Halozyme was a new Aster Capital Management position in Q2 2026.
  • Halozyme made up 0.08% of Aster Capital Management's portfolio in Q2 2026, its #304 holding.
  • Aster Capital Management first reported a position in Halozyme in Q2 2025 and has held it in 4 quarters since.
  • Aster Capital Management's Halozyme position peaked at $461K in Q2 2025.
  • 673 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Aster Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.